Ricursive Intelligence | $300,000,000 | (Jan 28, 2026)
Nerd Apply | $3,200,000 | (Jan 28, 2026)
Fiddler AI | $30,000,000 | (Jan 28, 2026) Certified by Founder
Lodge
GC Therapeutics
start up
United States
- Cambridge, MA
- 24/09/2024
- Series A
- $65,000,000
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases.
The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.
- Industry Biotechnology Research
- Website https://www.gc-tx.com/
- LinkedIn https://www.linkedin.com/company/gctx/
Jelou AI | $10,000,000 | (Jan 28, 2026)
Concourse | $12,000,000 | (Jan 28, 2026)
Summize | $50,000,000 | (Jan 28, 2026)
Opendate | $14,000,000 | (Jan 28, 2026)
Memcyco | $37,000,000 | (Jan 28, 2026)
Midship | $4,150,000 | (Jan 28, 2026)
Consio | $3,300,000 | (Jan 27, 2026)
Barnwell Bio | $6,000,000 | (Jan 27, 2026)
Orbital(US) | $60,000,000 | (Jan 27, 2026)